跳至主要内容
临床试验/NCT06289049
NCT06289049已完成2 期

Feasibility and Preliminary Efficacy of Heavy Lifting Strength Training Versus Usual Care in Head and Neck Cancer Survivors: A Randomized Controlled Trial

University of Alberta1 个研究点 分布在 1 个国家实际入组 37 人开始时间: 2025年2月17日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
37
试验地点
1
主要终点
Followup assessment rate

研究概览

简要总结

Despite improvements in treatments, head and neck cancer survivors (HNCS) still endure acute and chronic side effects such as loss of muscular strength, limitations in physical functioning, fatigue, and swallowing difficulties that impact quality of life (QoL) and limit return to work. Light-to-moderate intensity strength training (LMST) has been shown to improve some side effects. Heavy lifting strength training (HLST) may further improve outcomes in some populations, however, only one small pilot study has focused on HNCS. The LIFTING 2 trial will be the first to examine the feasibility and effects of a HLST program versus no exercise in HNCS.

详细描述

  1. Background and Rationale

Despite improvements in treatments, head and neck cancer survivors (HNCS) still endure acute and chronic side effects such as loss of muscular strength, limitations in physical functioning, fatigue, and swallowing difficulties that impact quality of life (QoL) and limit return to work. Light-to-moderate intensity strength training (LMST) has been shown to improve some side effects. Heavy lifting strength training (HLST) may further improve outcomes in some populations, however, only one small pilot study has focused on HNCS. 2. Research Question & Objectives

The primary aim of the proposed study is to further establish the feasibility of HLST in HNCS which will be based on the eligibility rate, recruitment rate, one-repetition max (3RM) testing rate, HLST program adherence, and follow-up assessment rate. A secondary aim is to provide preliminary evidence of the effects of a HLST program compared to usual care (UC) in HNCS. The primary efficacy outcome will be upper and lower muscular strength assessed by reliable 3-repetition maximum (3RM) tests on the chest press and leg press machines. Secondary efficacy outcomes include physical function, handgrip strength, body composition, QoL, fear of cancer recurrence, symptom burden, pain, anxiety, fatigue, stress, self-esteem, shoulder mobility, sleep, malnutrition status, and swallowing abilities. 3. Methods

This single-centre, two-armed, randomized controlled trial will recruit 60 HNCS ≥1-year posttreatment, and randomly assign them to the HLST group or UC group. For the HLST group, the 12-week exercise intervention will include supervised training 2 days per week. The HLST group will progress to lifting low repetitions of heavy loads at 80-90% of one repetition maximum (1RM), whereas the UC group will not receive any exercise prescription or instruction during the 12-week intervention, but will be offered a 4-week introduction to HLST program and/or referred to a community-based program after the postintervention assessments are complete. Assessments for both groups will occur at baseline and postintervention and include reliable 3RM strength tests, bioelectrical impedance analysis (BIA), Senior's Fitness Test, and validated QoL questionnaires.

研究设计

研究类型
干预性
分配方式
随机
干预模型
平行分组
主要目的
其他
盲法
开放(无盲法)

盲法说明

Participants and investigators will not be blinded to group assignment given the nature of the intervention.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • males and females, 18 years of age and older
  • any head and neck cancer subtype, stage, and treatment type
  • at least 1-year posttreatment with adequate shoulder range of motion (must meet minimum cutpoints for active flexion and abduction to be eligible)
  • no unmanaged medical conditions, alcohol, or drug abuse
  • approved for exercise by oncologist and a certified exercise physiologist or kinesiologist
  • ability to understand and communicate in English

排除标准

  • has met the Canadian Physical Activity strength training guidelines within the past one-month: at least two days per week of muscle and bone strength training activities using major muscle groups
  • currently involved in a different exercise trial or clinical drug trial

研究组 & 干预措施

Exercise Group

Experimental

The exercise intervention will consist of 24 supervised, heavy lifting strength training exercise sessions over a 12 week period. The exercise frequency will be two times per week. Main exercises will consist of barbell back squat, bench press, and dead lift.

干预措施: Experimental (Other)

Usual Care Group

No Intervention

Participants randomized to the usual care group will be asked to continue will their typical daily routine during the 12 week study period, and not begin any new exercise program to increase their exercise levels from baseline. They will not receive any information or education regarding exercise. After the postintervention assessments, participants in the usual care group will be offered a 4-week introduction to heavy lifting strength training program and/or referred to a community-based exercise program

结局指标

主要结局

Followup assessment rate

时间窗: Postintervention (12 weeks)

Followup assessment rate: 0 to 100 percent; Higher=better

Recruitment rate

时间窗: Baseline, postintervention (12 weeks), and monitored throughout 12 week study period

Recruitment range: 40 to 60 participants; Higher=better and more available data

Adherence to a heavy lifting strength training program

时间窗: Baseline, postintervention (12 weeks), and monitored throughout 12 week study period

Adherence rate: 0 to 100 percent of exercise sessions; Higher=better

Completion of maximal strength testing

时间窗: Baseline and postintervention (12 weeks)

3 repetition maximum testing rate: 0 to 100 percent; Higher=better

Safety

时间窗: Baseline, postintervention (12 weeks), and monitored throughout 12 week study period

Adverse events: minimum: no adverse events, maximum: no maximum. Higher=worse

次要结局

  • Handgrip Strength(Baseline and Postintervention (12 weeks))
  • Cancer Specific Quality of Life(Baseline and Postintervention (12 weeks))
  • Symptom Burden(Baseline and Postintervention (12 weeks))
  • Muscular Strength(Baseline and Postintervention (12 weeks))
  • Fear of Cancer Recurrence(Baseline and Postintervention (12 weeks))
  • Perceived Stress(Baseline and Postintervention (12 weeks))
  • Self-Esteem(Baseline and Postintervention (12 weeks))
  • Sleep Habits(Baseline and Postintervention (12 weeks))
  • Malnutrition Status(Baseline and Postintervention (12 weeks))
  • Swallowing Abilities(Baseline and Postintervention (12 weeks))
  • Shoulder Range of Motion(Baseline and Postintervention (12 weeks))
  • Body composition(Baseline and Postintervention (12 weeks))
  • Physical Function(Baseline and Postintervention (12 weeks))

研究者

申办方类型
其他
责任方
申办方

研究点 (1)

Loading locations...

标识符

NCT 编号
NCT06289049
其他研究编号
HREBA.CC-24-0021

日期

首次提交
(2年前)
首次发布
(2年前)
主要完成日期
(2个月前)
研究完成日期
(2个月前)
最近核实
(2个月前)
最近更新
(上个月)

监管与共享

FDA 监管药物
否
FDA 监管器械
否
个体参与者数据共享计划
否
是否有结果
否

相似试验